American Thyroid Association

This collection features commentaries, interviews, and slideshows developed by Medscape in collaboration with the American Thyroid Association. It is designed to advance the understanding of thyroid disorders and thyroid cancer, and to offer guidance to physicians, nurses, pharmacists, and the entire patient care team.

Editorial Collaboration

  • A New Frontier in Papillary Thyroid Cancer Treatment What is the best course of treatment for small, low-risk papillary thyroid cancer? New developments have created opportunities to deliver care in a more individualized manner.
  • 'Thyroid Diet': What's the Evidence? Can certain dietary changes benefit or harm thyroid health? What foods should be avoided, and which supplements consumed? Here are the answers to your patients' questions.
  • Assessing Thyroid Nodules: A Clinician's Guide Ultrasound of the thyroid and surrounding neck structures is the most important tool for differentiating benign from suspicious nodules.
  • Is Thyroid Disease Worsened by COVID? Little is known about the relationship between thyroiditis and COVID-19. How should clinicians answer patient questions about the potential risks and complications?
  • 'I Don't Want to Die': Surprising Fears About Thyroid Surgery An endocrinologist and endocrine surgeon discuss some surprising concerns and anxieties that patients may have before thyroid surgery.
  • Subclinical Hypothyroidism Balancing Act: Knowing When to Treat Dr Tyler Drake presents three cases and discusses the factors to consider when deciding whether or not to treat subclinical hypothyroidism.
  • Surgery for Persistent Symptoms in Hashimoto's Thyroiditis? A recent study compared thyroidectomy with medical management for persistent symptoms of Hashimoto's thyroiditis. But is surgery really the answer?
  • Levothyroxine Dosing: Morning, Night, or In Between? Clinicians have traditionally told patients to take levothyroxine first thing in the morning, at least an hour before any food or drink. But does it really matter? Dr Leung looks at the evidence.
  • Thyroid Cancer in 2019: Questions That Remain Unanswered What used to be a relatively rare malignancy, thyroid cancer diagnoses are now rising quickly. Dr Leung discusses what we currently know and some of the top questions that remain unanswered.
  • The Love-Hate Relationship With Levothyroxine Levothyroxine, despite being the most prescribed drug in the United States, has many patients disenchanted and looking to T3 for symptom relief. How should clinicians approach the T4/T3 controversy?


Transforming thyroid care through clinical excellence, education, scientific discovery, and advocacy in a collaborative community.